Special Alerts
Janus Kinase Inhibitors Safety ReviewNovember 2022
Health Canada has previously communicated on the risks of major adverse cardiovascular events (MACE), t...
Skip Nav Destination
This item requires a subscription.
For full access to this content, please log in to an existing user account or purchase an individual subscription.
If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
